Rayyan
Status:
watch-list| Maturity:production-ready| Last reviewed: 2026-03-04
What it does
Rayyan is a free, web-based tool for systematic review article screening and management. It uses AI to suggest screening decisions and supports collaborative review workflows, making it one of the most widely used tools in the systematic review community.
Key capabilities
- AI-assisted title and abstract screening recommendations
- Collaborative screening with multiple reviewers
- Blind and unblind review modes
- Conflict resolution between reviewers
- Import from standard reference formats (RIS, BibTeX, PubMed)
- Free tier sufficient for many research projects
Fit for Sheffield researchers
Widely adopted in the research community and free tier covers most use cases. A practical alternative or complement to Covidence, particularly for teams without institutional Covidence access. Suitable across health, social sciences, and other disciplines using systematic review methods.
Licensing and access
Free tier available for academic use. Institutional plans for larger teams. Low-friction starting point — researchers can begin immediately without procurement.
Trust and governance notes
GDPR compliance and data residency not confirmed. Standard caveats apply. Not recommended for systematic reviews involving sensitive personal data until governance is clarified.
Observed limitations
- AI screening suggestions require researcher validation
- Free tier has usage limitations for very large reviews
- Less feature-rich than Covidence for full systematic review management
Related tools
Sources and evidence
- Rayyan product page: https://www.rayyan.ai/ (accessed 2026-03-04)